HomeTagsB-cell lymphoma

B-cell lymphoma

Biotechnology

EPKINLY Approved by U.S. FDA as the First and Only Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

PR Newswire - May 22, 2023

AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved EPKINLY, as the first and only T-cell engaging bispecific antibody for the...

Biotechnology

FDA Approves Genentech’s Polivy in Combination With R-CHP for People With Certain Types of Previously Untreated Diffuse Large B-cell Lymphoma

Business Wire - April 20, 2023

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved Polivy in combination with Rituxan, cyclophosphamide,...